US EditionRejection of Bispecific Antibodies for Lymphoma Leaves some Patients Completely without Options
Summary by medicinsketidsskrifter.dk
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
HAEMATOLOGICAL JOURNAL Refusal of bispecific antibodies for lymphoma leaves some patients completely without options It will cost lives and it risks affecting the overall survival (OS) among patients with diffuse large B-cell lymphoma (DLBCL). These are the gloomy reports from a number of prominent doctors after the Danish Medical Council rejected the standard use of bispecific antibodies for DLBCL. Without access to bispecific antibodies, selec…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
